Marshman Fund Trust II - 31 Dec 2024 SCHEDULE 13G/A Report for Harmony Biosciences Holdings, Inc. Common Stock, par value $0.00001 per share (HRMY)

Filing Manager
Marshman Fund Trust II
Reporting Manager
Marshman Fund Trust II
Security
Harmony Biosciences Holdings, Inc. Common Stock, par value $0.00001 per share
Symbol
HRMY
Shares outstanding
57,086,038 shares
Disclosed Ownership
6,051,120 shares
Ownership
11%
Form type
SCHEDULE 13G/A
Filing time
10 Feb 2025, 16:30:10 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Quoteable Key Fact

"Marshman Fund Trust II disclosed 11% ownership in Harmony Biosciences Holdings, Inc. Common Stock, par value $0.00001 per share (HRMY) on 31 Dec 2024."

Quick Takeaways

  • Marshman Fund Trust II filed SCHEDULE 13G/A for Harmony Biosciences Holdings, Inc. Common Stock, par value $0.00001 per share (HRMY).
  • Disclosed ownership: 11%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 10 Feb 2025, 16:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Marshman Fund Trust II 11% 6,051,120 6,051,120 0 /s/ Charles Harris Charles Harris, Co-Trustee